Ushbu ish iqtibos qilgan ishlar

121 ta ish

Ish: Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Sharh maqola20256 iqtibos
ABI
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
Atieh Raoufi, Hamed Soleimani Samarkhazan, Sina Nouri +5
Sharh maqola20255 iqtibos
ABI
Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53
Leila Rajabi, Mostafa Ebrahimdoost, Seyed Amin Mohammadi +3
Maqola20255 iqtibos
ABI
Role of Precision Medicine and Personalized Medicine in the Treatment of Diseases
Mehrdad Farrokhi, Fatemeh Taheri, Parisa Jafari Khouzani +25
Kitob20234 iqtibos
ABI
Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis
Aziz Kubaev, Fadhil Faez Sead, Mohammad Pirouzbakht +6
Sharh maqolaExtracellular vesicles in diseaseJournal of Liposome Research20254 iqtibos
ABI
Aptamers used for biosensors and targeted therapy
Yi Ning, Jue Hu, Fangguo Lu
Sharh maqola20203 iqtibos
ABI
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Sharh maqola20183 iqtibos
ABI
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Tatsuo Adachi, Yoshikazu Nakamura
Sharh maqola20193 iqtibos
ABI
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel, Dirk Zboralski, Christian Maasch +5
Maqola20132 iqtibos
ABI
Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
Elizabeth D. Pratico, Bruce A. Sullenger, Smita K. Nair
Maqola20122 iqtibos
ABI
Aptamers and aptamer targeted delivery
Amy Yan, Matthew Levy
Sharh maqola20092 iqtibos
ABI
Aptamers: current challenges and future prospects
Guido Tomás Rozenblum, Vanina Gisela Lopez, Alfredo Daniel Vitullo +1
Sharh maqola20152 iqtibos
ABI
Aptamers: A promising chemical antibody for cancer therapy
Gang Zhou, George D. Wilson, Lionel Hebbard +4
Sharh maqola20162 iqtibos
ABI
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou, John J. Rossi
Sharh maqola20162 iqtibos
ABI
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Shuaijian Ni, Zhenjian Zhuo, Yufei Pan +12
Sharh maqola20202 iqtibos
ABI
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
Prabir Kumar Kulabhusan, Babar Hussain, Meral Yüce
Sharh maqola20202 iqtibos
ABI
Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy
Jing Han, Liang Gao, Jinsheng Wang +1
Sharh maqola20202 iqtibos
ABI
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Kaylin G. Earnest, Erin M. McConnell, Eman M. Hassan +8
Maqola20212 iqtibos
ABI
Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy
Yue Lang, Yanan Lyu, Yehui Tan +1
Sharh maqola20232 iqtibos
ABI
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Ali Rahmati +3
Sharh maqola20252 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI